Lloyd George W.

EVP Lloyd George W. liquidates entire RPRX stake: 110,000 shares ($4.2M) in two sales on 12/17–12/18 at $38.57–$38.50.

Lloyd George W., EVP of Investments & CLO, executed two separate sales totaling 110,000 shares for $4,240,333.32 at a blended average price of $38.55, eliminating his entire holdings and reducing his post-transaction position to zero shares. The sales occurred on 2025-12-17 and 2025-12-18 at prices ($38.57 and $38.50) nearly aligned with the current price of $38.60, placing the execution near recent resistance levels. Across his cross-ticker track record, his prior 13 sells posted an average 90-day return of -10.7% with a 90-day well-timed rate of 100.00%, but at RPRX specifically his prior five trades lack measurable 90-day outcomes, limiting inference about his timing precision at this ticker. The complete liquidation of a significant executive position warrants attention given the company's current fundamentals—net income of $288,217,000.00 against revenue of $609,291,000.00—and his operational role in capital allocation decisions.

EVP Lloyd George W. sold 110,000 shares of Royalty Pharma at $39.77, halving stake to 110,000 shares.

Lloyd George W., EVP of Investments & CLO, executed a substantial sale of 110,000 shares (110.0K shares) at $39.77 on 2025-12-03, reducing his holdings by 50.0% to 110,000 shares (110.0K shares). The transaction totaled $4,375,008.00 ($4.4M). At current price of $39.73, the stock is -2.6% from its 52-week high of $40.78, suggesting the sale occurred near recent peak valuations. His cross-ticker track record shows a 100.00% well-timed rate on 12 prior sells with an average 90-day return of -10.7%, but at RPRX specifically, five prior sales on 2025-11-19 remain without measurable 90-day outcomes. The company's fundamentals show annual revenue decline of -3.9%, modest P/E of 20.17, and solid profitability with net income of $288,217,000.00 ($288.2M) on revenue of $609,291,000.00 ($609.3M). The halving of a senior investment officer's stake warrants attention to whether subsequent price action or company developments justify the liquidation timing.

Lloyd George W. (EVP, Investments & CLO) sold entire 135.4K-share RPRX position for $5.2M across 8 transactions on 2025-11-19 at $38.34 blended average.

Lloyd George W., EVP of Investments & CLO, executed a complete liquidation of his RPRX holdings through 8 separate sales totaling 135,426 shares for $5,192,656.18 on a single trading day. The transaction prices ranged from $38.28 to $39.03, with a blended average of $38.34—slightly below the current price of $38.92 and 4.6% below the 52-week high of $40.78. Notably, his prior 4 sales at RPRX were all well-timed at the 90-day mark, with negative post-transaction returns ranging from -8.3% to -10.5%, establishing a consistent pattern of selling before declines; however, this complete exit on a single date removes all insider equity stakes and should be flagged for investor attention as a signal of material conviction about near-term valuation or market conditions. The stock is up 5.6% over 30 days and 7.2% over 90 days, suggesting this sale occurred in a period of relative strength rather than distress, which contrasts with the typical declining-market context of his prior sells.